PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | citybiz
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology falls more than 20%
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Articles with Puma Biotechnology
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
News Release
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Puma Biotech News, Puma Biotech Quote, PBYI Quote - StreetInsider.com
